Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function.
Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function.
复制标题
DOI:
10.1016/j.pharep.2014.12.004
复制
发表时间:
2015-06
期刊:
影响因子:
--
通讯作者:
Bartlett MG
中科院分区:
文献类型:
--
作者:
Li P;Beck WD;Callahan PM;Terry AV Jr;Bartlett MG
Attention has been paid to cotinine (COT), one of the major metabolites of nicotine (NIC), for its pro-cognitive effects and potential therapeutic activities against Alzheimer's Disease (AD) and other types of cognitive impairment. In order to facilitate pharmacological and toxicological studies on COT for its pro-cognitive activities, we conducted a pharmacokinetic (PK) study of COT in rats, providing important oral and intravenously (IV) PK information. In this study, plasma samples were obtained up to 48 hours after COT was dosed to rats orally and IV at a dose of 3 mg/kg. Plasma samples were prepared and analyzed using a sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) bioanalytical method, providing concentration profiles of COT and metabolites after oral and IV administrations. The data were fitted into a one-compartment model and a two-compartment model for the oral and IV groups, respectively, providing important PK information for COT including PK profiles, half-life, clearance and bioavailability. The results suggested fast absorption, slow elimination and high bioavailability of COT in rats. Several important facts about the PK properties in rats suggested COT could be a potential pro-cognitive agent. Information about the pharmacokinetics of COT in rats revealed in this study is of great importance for the future studies on COT or potential COT analogues as agents for improving cognition.